#glp-1
30 stories
Roche Bets $1.16 Billion on RNAi Weight-Loss Therapy
Roche secures $1.16 billion RNAi weight-loss drug deal with Rona Therapeutics.
BigGo Finance · 1m
I chose dance over GLP-1s to lose weight
After friends pushed her toward weight-loss drugs, Leslie Vooris found her answer on the dance floor instead.
Business Insider · 2m
Bayer Targets GLP-1 Side Effect Solutions for India
Bayer plans to launch products addressing GLP-1 drug side effects in India by 2030.
The Economic Times · 1m
GLP-1 Muscle Growth Plan
GLP-1 users can build muscle with this 4-week workout plan.
Men's Health · 1m
Sorority Rush Gets Ozempic Makeover
College women use weight-loss injections to compete in sorority rush.
Fox News · 2m
Noom Ad Highlights GLP-1 Weight Rebound Fears
Noom's dystopian ad warns GLP-1 users about weight rebound risks after stopping medication.
Adweek · 1m
Amy Hamm: Ozempic as Genocide Tool
Socialists claim Ozempic fuels genocide against fat people.
Nationalpost · 1m
The fiber trend taking over TikTok
Fibermaxxing is helping Americans eat an underconsumed nutrient, but the internet's obsession with it risks turning a sound health practice into another extreme wellness fad.
The Verge · 3m
Viking Soars Alone as Obesity Complex Shrugs
Viking Therapeutics jumps 26.5% after GLP-1 results while obesity peers barely move.
24/7 Wall St. · 1m
Hundreds of Lawsuits Claim GLP-1s Caused Permanent Vision Loss
Hundreds of lawsuits allege GLP-1 weight-loss drugs caused permanent vision loss.
Valleynewslive · 1m
AI Food Delivery and Rye Bread
DoorDash tests AI ordering while rye bread costs $60.
Bon Appétit · 1m
Novo CEO eyes M&A deals as weight-loss dominance slips
Novo Nordisk's turnaround plan failed to convince investors, prompting CEO Mike Doustdar to signal openness to acquisitions beyond obesity drugs.
CNBC · 2m
Stavros Halkias Worries Fame Might Kill Him
Comedian Stavros Halkias fears fame could harm his health.
Slate Magazine · 1m
Travelling with weight loss medication: 12 things I wish I’d known
How to travel safely with weight loss injections like Mounjaro.
Wellbeing Magazine · 2m
Megan Fox Ro Sparks ED Campaign
Megan Fox stars in Ro's first ED campaign as product personified.
Adweek · 1m
Psychiatrists Prescribe GLP-1s for Mental Health
Some psychiatrists use GLP-1 medications to treat depression and anxiety.
Bon Appétit · 1m
Obesity drug cuts weight by 25 percent in trial
Retatrutide, a triple-acting hormone treatment from Eli Lilly, showed the strongest weight loss results yet in late-stage testing.
Ars Technica · 2m
Eli Lilly's Tough Month: Bank Predicts 37% Gains
Citi forecasts 37% stock gains for Eli Lilly as selloff ends.
24/7 Wall St. · 1m
Illinois Gov. Pritzker Shares 80-Pound Weight Loss with GLP-1
Illinois Gov. Pritzker reveals GLP-1 use after 80-pound weight loss.
Chicago Sun-Times · 2m
GLP-1 Users Face Rare Vision Loss Risk
GLP-1 drugs may cause rare vision loss, but benefits outweigh risks for most.
ABC7 New York · 1m
GLP-1 and Weed Munchies: Do They Clash?
GLP-1 drugs may weaken cannabis cravings but not eliminate them.
Men's Health · 1m
Zydus Targets New Growth Areas
Zydus Lifesciences plans to expand into specialty medicines and biologics while maintaining US generics.
The Economic Times · 1m
Telehealth companies leak medical data without permission
Telehealth firms share health data with advertisers and search engines after promising privacy
ABC7 New York · 1m
Nvidia vs. Eli Lilly: Which Stock Wins Next Decade?
Nvidia's AI infrastructure and Eli Lilly's GLP-1 drugs both surged, but which stock has the cleaner path to 10-year growth?
24/7 Wall St. · 1m
McDonald's $8.5B NEXT Plan for Franchise Upgrades
McDonald's $8.5 billion investment to modernize 250,000+ restaurants with AI, efficiency gains, and protein-focused menu changes by 2036
Dallas Express · 1m
Novo Nordisk Stock Drops 7% After Growth Plan Fails to Ease Competition Fears
Novo Nordisk's stock falls 7% as its post-Wegovy growth plan fails to reassure investors about competition risks
24/7 Wall St. · 1m
What to know before starting GLP-1 weight loss drugs
These medications do more than help you lose weight, but they're not right for everyone.
Valleynewslive · 1m
Are GLP-1s the New Statins?
Cardiologists say Ozempic protects the heart in ways that have little to do with the number on the scale.
Men's Health · 2m
A rare brain risk hiding behind GLP-1 weight loss
Fifteen cases of a vitamin B1 brain disorder turned up in people on Ozempic, Wegovy, Mounjaro and Zepbound.
Fox News · 1m
The secret shame of the Ozempic era
GLP-1 users are losing weight and hiding it from the people closest to them.
Futurism · 1m